Novo Nordisk steps up interest in diabetes, Parkinson’s stem cell therapies

Novo Nordisk steps up interest in diabetes, Parkinson’s stem cell therapies

Source: 
Fierce Biotech
snippet: 

Novo Nordisk has talked up the progress of its Type 1 diabetes stem cell therapy program. With the diabetes project clearing milestones and moving to within a few years of the clinic, Novo is stepping up its interest in stem cell therapies more broadly.